Unknown

Dataset Information

0

Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data.


ABSTRACT: Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological malignancies, including B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (ALL). The treatment is currently also being studied in other B-cell neoplasms, including multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). CD19 and B-cell maturation antigen (BCMA) have been the most popular target antigens for CAR-T-cell immunotherapy of these malignancies. This review will discuss the efficacy and toxicity data from the pivotal clinical studies of CD19- and BCMA-targeted CAR-T-cell therapies in relapsed/refractory B-cell malignancies (NHL, ALL, CLL) and MM, respectively.

SUBMITTER: Roex G 

PROVIDER: S-EPMC7076393 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data.

Roex Gils G   Feys Tom T   Beguin Yves Y   Kerre Tessa T   Poiré Xavier X   Lewalle Philippe P   Vandenberghe Peter P   Bron Dominique D   Anguille Sébastien S  

Pharmaceutics 20200224 2


Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological malignancies, including B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (ALL). The treatment is currently also being studied in other B-cell neoplasms, including multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). CD19 and B-cell maturation antigen (BCMA) have been the most popular target antigens for CAR-  ...[more]

Similar Datasets

| S-EPMC8019219 | biostudies-literature
| S-EPMC6006225 | biostudies-literature
| S-EPMC5738277 | biostudies-literature
| S-EPMC7547336 | biostudies-literature
| S-EPMC7564024 | biostudies-literature
| S-EPMC7422135 | biostudies-literature
2022-09-08 | GSE192453 | GEO
| S-EPMC6566309 | biostudies-literature
| S-EPMC6756044 | biostudies-literature
2021-08-23 | GSE179414 | GEO